Summit Therapeutics Inc. (SMMT)
NASDAQ · Healthcare
Summit Therapeutics Inc. Cash on Hand 2019–2024
Summit Therapeutics Inc. annual/quarterly cash on hand history from 2019 to 2024. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- Summit Therapeutics Inc. cash on hand for the quarter ending December 31, 2024 were 104.9M, a 46.81% increase year-over-year.
- Summit Therapeutics Inc. cash on hand for 2024 were 104.9M, a 46.81% increase from 2023.
- Summit Therapeutics Inc. cash on hand for 2023 were 71.4M, a 79.51% decrease from 2022.
- Summit Therapeutics Inc. cash on hand for 2022 were 348.6M, a 385.59% increase from 2021.
- Summit Therapeutics Inc. cash on hand for 2021 were 71.8M.
Cash on Hand
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Summit Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2024 | $105 |
| 2023 | $71 |
| 2022 | $349 |
| 2021 | $72 |
| 2020 | $66 |
| 2019 | $64 |
| Summit Therapeutics Inc. Quarterly Cash on Hand (Millions of US $) | |
|---|---|
| 2024-12-31 | $105 |
| 2023-12-31 | $71 |
| 2022-12-31 | $349 |
| 2021-12-31 | $72 |
| 2020-12-31 | $66 |
| 2019-12-31 | $64 |
Summit Therapeutics Inc. Cash on Hand — FAQ
Summit Therapeutics Inc. (SMMT) cash on hand over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SMMT's cash on hand history?
The chart and table above show Summit Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.